Exagen Inc. To Participate in 2021 ICR Conference
05 janv. 2021 16h05 HE
|
Exagen Inc.
SAN DIEGO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today...
Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer
24 mars 2020 08h25 HE
|
Exagen, Inc.
SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced...
Exagen to Announce Fourth Quarter and Year-End 2019 Financial Results on March 25, 2020
11 mars 2020 08h25 HE
|
Exagen, Inc.
SAN DIEGO, March 11, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen to Present at Cowen and Company 40th Annual Healthcare Conference
18 févr. 2020 08h25 HE
|
Exagen, Inc.
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
Exagen Diagnostics to Present Six Scientific Posters at 2016 ACR/ARHP Annual Meeting
12 oct. 2016 08h32 HE
|
Exagen Diagnostics, Inc.
SAN DIEGO, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Exagen Diagnostics to feature six poster presentations on AVISE® testing at the American College of Rheumatology’s (ACR) annual meeting being held...